Ulrike Kamecke

Measurement Performance of Two Continuous Tissue Glucose Monitoring Systems Intended for Replacement of Blood Glucose MonitoringParts of the data have previously been presented at the 77th Scientific Sessions of the American Diabetes Association in San Diego, CA; June 9–13, 2017 and at the 17th Annual Diabetes Technology Meeting in Bethesda, MD, November 2–4, 2017.Trial number: DRKS00011920; registered at the Deutsches Register Klinischer Studien (German clinical trials register), an approved Primary Register in the WHO International Clinical Trials Registry Platform.

Guido Freckmann, Manuela Link, Stefan Pleus et al. · Diabetes Technology & Therapeutics · 2018 · 59 citations · Full text

Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems

Guido Freckmann, Ulrike Kamecke, Delia Waldenmaier et al. · Diabetes Technology & Therapeutics · 2019 · 35 citations · Full text

Performance and Usability of Three Systems for Continuous Glucose Monitoring in Direct Comparison

Guido Freckmann, Manuela Link, Ulrike Kamecke et al. · Journal of Diabetes Science and Technology · 2019 · 34 citations · Full text

Continuous glucose monitoring in interstitial fluid using glucose oxidase-based sensor compared to established blood glucose measurement in rats

Stefanie Woderer, Nadja Henninger, Claus-Dieter Garthe et al. · Analytica Chimica Acta · 2006 · 33 citations

Blood Glucose Measurement, Bioanalysis, Diabetes +9

Time in Specific Glucose Ranges, Glucose Management Indicator, and Glycemic Variability: Impact of Continuous Glucose Monitoring (CGM) System Model and Sensor on CGM Metrics

Stefan Pleus, Ulrike Kamecke, Delia Waldenmaier et al. · Journal of Diabetes Science and Technology · 2020 · 29 citations · Full text